CSF3 and graft versus host disease: Given the history of aGvHD and that Granulocyte Colony Stimulating Factor (G-CSF)-mobilized human peripheral blood mononuclear cells (G-hPBMCs) are known risk factors for cGvHD[15], we tested whether G-hPBMCs with a modified conditioning regimen can give sub-acute inflammation leading to lasting GvHD with cGvHD manifestations in the humanized mouse system.